[1] | Infectious Diseases Physicians Branch, Chinese Medical Doctor Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus (version 2024)[J]. Journal of Clinical Hepatology, 2024, 40(8): 1557-1566. doi: 10.12449/JCH240809 |
[2] | Jianing KONG, Binbin ZHANG, Junping SHI. An excerpt of clinical practice guideline of prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (2024 edition)[J]. Journal of Clinical Hepatology, 2024, 40(9): 1767-1770. doi: 10.12449/JCH240908 |
[3] | Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2024 version)[J]. Journal of Clinical Hepatology, 2024, 40(12): 2371-2387. doi: 10.12449/JCH241206 |
[4] | Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. Journal of Clinical Hepatology, 2019, 35(1): 38-44. doi: 10.3969/j.issn.1001-5256.2019.01.007 |
[5] | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy (2015)[J]. Journal of Clinical Hepatology, 2015, 31(10): 1575-1578. doi: 10.3969/j.issn.1001-5256.2015.10.003 |
[6] | Chinese Society of Organ TransplantationChinese Medical Association;. Guidelines for application of tacrolimus in clinical liver transplantation[J]. Journal of Clinical Hepatology, 2015, 31(9): 1372-1374. doi: 10.3969/j.issn.1001-5256.2015.09.002 |
[7] | Zhu Peng, Xu Zong, Wang YuMing. Updated key points and clinical pathway for NCCN Clinical Practice Guidelines in Oncology: hepatobiliary cancers(Version 2. 2015)[J]. Journal of Clinical Hepatology, 2015, 31(6): 840-849. doi: 10.3969/j.issn.1001-5256.2015.06.005 |
[8] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of chronic pancreatitis(2014)[J]. Journal of Clinical Hepatology, 2015, 31(3): 322-326. doi: 10.3969/j.issn.1001-5256.2015.03.002 |
[9] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Associati. Guidelines for the management of pancreatic cystic lesions(2015)[J]. Journal of Clinical Hepatology, 2015, 31(9): 1375-1378. doi: 10.3969/j.issn.1001-5256.2015.09.003 |
[10] | Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2015, 31(11): 1752-1769. doi: 10.3969/j.issn.1001-5256.2015.11.002 |
[11] | Chinese Society of Liver Cancer, Chinese Anti-Cancer Association, Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Pathology, Chinese Anti-Cancer Association, Digestive Disease Group, Chinese Society of Pathology, Chinese Medical Association, epatic Surgery Group, Chinese Society of Surgery, Chinese Medical Association, Chinese Society of Clinical Oncology, Chinese Anti-Cancer Association, Chinese Pathological Group of Hepatobiliary Tumor and Liver Transplantation. Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China( 2015 update)[J]. Journal of Clinical Hepatology, 2015, 31(6): 833-839. doi: 10.3969/j.issn.1001-5256.2015.06.004 |
[12] | Wang Ran, Qi XingShun, Guo XiaoZhong. LI-RADS Management Working Group consensus on the diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(11): 1791-1795. doi: 10.3969/j.issn.1001-5256.2015.11.006 |
[13] | Wu YinLian, Lin Su, Dong Jing, Jiang JiaJi. Interpretation of key points in Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)[J]. Journal of Clinical Hepatology, 2015, 31(6): 850-851. doi: 10.3969/j.issn.1001-5256.2015.06.006 |
[14] | Zhao JianCheng, Qi XingShun, Guo XiaoZhong. 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma: an excerpt of recommendations[J]. Journal of Clinical Hepatology, 2015, 31(7): 1031-1033. doi: 10.3969/j.issn.1001-5256.2015.07.008 |
[15] | Li XiaoQing, Qian JiaMing. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline-Updated June 2014[J]. Journal of Clinical Hepatology, 2014, 30(12): 1236-1239. doi: 10.3969/j.issn.1001-5256.2014.12.002 |
[16] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of pancreatic neuroendocrine neoplasms (2014)[J]. Journal of Clinical Hepatology, 2014, 30(12): 1246-1248. doi: 10.3969/j.issn.1001-5256.2014.12.004 |
[17] | Expert Panel of Antiviral Therapy for Hepatocellular Carcinoma. Expert consensus on antiviral therapy to hepatitis B/C virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(5): 390-395. doi: 10.3969/j.issn.1001-5256.2014.05.002 |
[18] | Dong Jing, Jiang JiaJi. Explanation of the“Expert consensus on antiviral therapy to hepatitis B /C virus-related hepatocellular carcinoma”[J]. Journal of Clinical Hepatology, 2014, 30(7): 592-595. doi: 10.3969/j.issn.1001-5256.2014.07.004 |
[19] | Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis ( Shanghai, 2013)[J]. Journal of Clinical Hepatology, 2013, 29(9): 656-660. doi: 10.3969/j.issn.1001-5256.2013.09.006 |
[20] | Jia JiDong, Li LanJuan. The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J]. Journal of Clinical Hepatology, 2011, 27(1): 113-128. |